<DOC>
	<DOCNO>NCT01820104</DOCNO>
	<brief_summary>Oral hypoglycemic medication sometimes control type 2 diabetes well . Proton pump inhibitor ( PPIs ) adjunctive therapy might improve diabetes control could enhance hypoglycemic activity DPP4 , little clinical data efficacy therapeutic strategy . The investigator seek examine effect PPI lansoprazole , DPP-4 inhibitor sitagliptin , combination therapy insulin glucose regulation healthy subject oral glucose tolerance ( OGTT ) .</brief_summary>
	<brief_title>Effects Lansoprazole Sitagliptin Glucose-lowering Ability Healthy Males : Randomised Crossover Study</brief_title>
	<detailed_description>Oral hypoglycemic medication sometimes control type 2 diabetes well . Proton pump inhibitor ( PPIs ) adjunctive therapy might improve diabetes control could enhance hypoglycemic activity DPP4 , little clinical data efficacy therapeutic strategy . We seek examine effect PPI ( lansoprazole ) , DPP4 ( sitagliptin ) , combination therapy insulin glucose regulation healthy subject oral glucose tolerance ( OGTT ) .</detailed_description>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>General good health condition Male subject , 18 50 year Exclusion Criteria Overweight ( Body Mass Index â‰¥30 ) Metabolic disorder History gastrointestinal disorder Regular ( daily ) intake medication Smoking 10 cigarettes/day History drug abuse Exhaustive ( &gt; 3 units/day ) alcohol consumption Exhaustive ( &gt; 5 units/day ) caffeine consumption ( coffee , tea , cola , caffeine base drink ) Recent ( last 14 day ) donation blood Recent ( last 2 day ) donation blood plasma Participation another trial within 4 week start study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>